Mie Nishio

409 total citations
13 papers, 353 citations indexed

About

Mie Nishio is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Mie Nishio has authored 13 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Pharmacology. Recurrent topics in Mie Nishio's work include Receptor Mechanisms and Signaling (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Inflammatory mediators and NSAID effects (4 papers). Mie Nishio is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Inflammatory mediators and NSAID effects (4 papers). Mie Nishio collaborates with scholars based in Japan. Mie Nishio's co-authors include Yasuhiro Kita, Keizo Yoshida, Jiro Seki, Yoshimi Hirasawa, Yasuko Kato, Kazuhiro Maeda, Yukio Motoyama, Kiyotaka Ito, Toshio Yamanaka and Kayoko Mihara and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology and Atherosclerosis.

In The Last Decade

Mie Nishio

13 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mie Nishio Japan 8 135 117 81 79 48 13 353
Yoshimi Hirasawa Japan 11 296 2.2× 79 0.7× 34 0.4× 127 1.6× 100 2.1× 22 480
Russell D. Cousins United States 7 203 1.5× 82 0.7× 28 0.3× 173 2.2× 41 0.9× 7 500
James A. Lynham United Kingdom 13 141 1.0× 177 1.5× 68 0.8× 420 5.3× 17 0.4× 14 590
Marı́a del Carmen Boyano-Adánez Spain 13 62 0.5× 53 0.5× 54 0.7× 300 3.8× 31 0.6× 25 469
J D Vickers Canada 14 45 0.3× 79 0.7× 135 1.7× 178 2.3× 23 0.5× 28 496
N. Thompson United Kingdom 10 176 1.3× 37 0.3× 47 0.6× 442 5.6× 28 0.6× 18 672
L Wolfe United States 8 222 1.6× 71 0.6× 36 0.4× 328 4.2× 14 0.3× 9 450
DM Shasby United States 6 128 0.9× 40 0.3× 26 0.3× 175 2.2× 38 0.8× 8 386
P. Schanzenbächer Germany 12 125 0.9× 460 3.9× 144 1.8× 177 2.2× 12 0.3× 30 782
Jean W. Assender United Kingdom 11 139 1.0× 90 0.8× 20 0.2× 243 3.1× 23 0.5× 13 423

Countries citing papers authored by Mie Nishio

Since Specialization
Citations

This map shows the geographic impact of Mie Nishio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mie Nishio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mie Nishio more than expected).

Fields of papers citing papers by Mie Nishio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mie Nishio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mie Nishio. The network helps show where Mie Nishio may publish in the future.

Co-authorship network of co-authors of Mie Nishio

This figure shows the co-authorship network connecting the top 25 collaborators of Mie Nishio. A scholar is included among the top collaborators of Mie Nishio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mie Nishio. Mie Nishio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Tanaka, Akira, Kouji Hattori, Osamu Okitsu, et al.. (2006). Replacing the cyclohexene-linker of FR181157 leading to novel IP receptor agonists: Orally active prostacyclin mimetics. Part 6. Bioorganic & Medicinal Chemistry Letters. 16(18). 4861–4864. 10 indexed citations
2.
Tanaka, Akira, et al.. (2006). Metabolism investigation leading to novel drug design 2: Orally active prostacyclin mimetics. Part 5. Bioorganic & Medicinal Chemistry Letters. 16(17). 4475–4478. 6 indexed citations
3.
Hattori, Kouji, et al.. (2005). Discovery of new diphenyloxazole derivatives containing a pyrrolidine ring: Orally active prostacyclin mimetics. Part 2. Bioorganic & Medicinal Chemistry Letters. 15(13). 3279–3283. 8 indexed citations
4.
Hattori, Kouji, Akira Tanaka, Hisashi Takasugi, et al.. (2005). Metabolism investigation leading to novel drug design: Orally active prostacyclin mimetics. Part 4. Bioorganic & Medicinal Chemistry Letters. 15(13). 3284–3287. 2 indexed citations
5.
Hattori, Kouji, Akira Tanaka, Osamu Okitsu, et al.. (2005). Discovery of diphenylcarbamate derivatives as highly potent and selective IP receptor agonists: Orally active prostacyclin mimetics. Part 3. Bioorganic & Medicinal Chemistry Letters. 15(12). 3091–3095. 14 indexed citations
6.
Hattori, Kouji, Akira Tanaka, Osamu Okitsu, et al.. (2005). Discovery of Diphenylcarbamate Derivatives as Highly Potent and Selective IP Receptor Agonists: Orally Active Prostacyclin Mimetics. Part 3.. ChemInform. 36(44). 2 indexed citations
7.
Kato, Yasuko, Yasuhiro Kita, Mie Nishio, et al.. (2003). Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig. European Journal of Pharmacology. 473(2-3). 163–169. 75 indexed citations
8.
Kato, Yasuko, Yasuhiro Kita, Mie Nishio, et al.. (1999). In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist. European Journal of Pharmacology. 384(2-3). 197–202. 46 indexed citations
9.
Hirasawa, Yoshimi, Yasuko Kato, Mie Nishio, et al.. (1997). Structure-Activity Relationships of Spontaneous Nitric Oxide Releasers, FK409 and its Derivatives. Journal of Pharmacology and Experimental Therapeutics. 282(1). 236–242. 7 indexed citations
10.
Hirasawa, Yoshimi, Mie Nishio, Kazuhiro Maeda, Keizo Yoshida, & Yasuhiro Kita. (1995). Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue. European Journal of Pharmacology. 272(1). 39–43. 14 indexed citations
11.
Seki, Jiro, Mie Nishio, Yasuko Kato, Yukio Motoyama, & Keizo Yoshida. (1995). FK409, a new nitric-oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty. Atherosclerosis. 117(1). 97–106. 59 indexed citations
12.
Motoyama, Yukio, et al.. (1994). Effect of TFC-612, a 7-thia prostaglandin El derivative, on intimal thickening after endothelial injury with balloon catheter in rats. Atherosclerosis. 108(2). 159–165. 6 indexed citations
13.
Kita, Yasuhiro, Yoshimi Hirasawa, Kazuhiro Maeda, Mie Nishio, & Keizo Yoshida. (1994). Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. European Journal of Pharmacology. 257(1-2). 123–130. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026